Prevention for moderate or severe BPD with intravenous infusion of autologous cord blood mononuclear cells in very preterm infants-a prospective non-randomized placebo-controlled trial and two-year follow up outcomes
Open Access
- 16 February 2023
- journal article
- research article
- Published by Elsevier in eClinicalMedicine
- Vol. 57, 101844
Abstract
No abstract availableKeywords
Funding Information
- National Centre for Natural Science and Technology (2021YFC2701700)
- National Natural Science Foundation of China (8187060625, 82101817, 82171714)
- Guangzhou Municipal Science and Technology Program key projects (202102080104)
- National Key Research and Development Program of China
This publication has 37 references indexed in Scilit:
- Effects of human umbilical cord blood mononuclear cells on respiratory system mechanics in a murine model of neonatal lung injuryExperimental Lung Research, 2017
- Refining anti‐inflammatory therapy strategies for bronchopulmonary dysplasiaJournal of Cellular and Molecular Medicine, 2016
- Preterm cord blood CD4+ T cells exhibit increased IL-6 production in chorioamnionitis and decreased CD4+ T cells in bronchopulmonary dysplasiaHuman Immunology, 2015
- Umbilical cord blood CD34+ stem cells and other mononuclear cell subtypes processed up to 96 h from collection and stored at room temperature maintain a satisfactory functionality for cell therapyVox Sanguinis, 2014
- Alterations in Regulatory T Cell Subpopulations Seen in Preterm InfantsPLOS ONE, 2014
- Mesenchymal Stem Cells for Bronchopulmonary Dysplasia: Phase 1 Dose-Escalation Clinical TrialThe Journal of Pediatrics, 2014
- Feasibility of Autologous Cord Blood Cells for Infants with Hypoxic-Ischemic EncephalopathyThe Journal of Pediatrics, 2014
- Bronchopulmonary DysplasiaAdvances in Neonatal Care, 2014
- Bronchopulmonary DysplasiaAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Sample size tables for logistic regressionStatistics in Medicine, 1989